This article describes the trajectory of adherence patterns among users of sodium-glucose cotransporter 2 (SGLT2) inhibitors. The authors found that baseline factors were unable to predict the adherence trajectory groups.
Todd A. Lee, PhD
Advertisement
Articles by Todd A. Lee, PhD
A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.
Advertisement
Latest Updated Articles
Adherence Patterns 1 Year After Initiation of SGLT2 Inhibitors: Results of a National Cohort StudyPublished: August 7th 2024 | Updated:
- Claims-Based Risk Model for First Severe COPD Exacerbation
Published: February 17th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
3
Teclistamab for R/R MM Effective and Safe When Administered in a Community Setting
4
Childhood Insurance Dynamics Predict Medicaid Cuts Will Widen Gaps
5
